Diabetes Metab J.  2015 Oct;39(5):434-438. 10.4093/dmj.2015.39.5.434.

Relationship between Biological Markers, Metabolic Components, Lifestyles, and Impaired Fasting Glucose in Male Workers

• Kawada T

• KMID: 2174017
• DOI: http://doi.org/10.4093/dmj.2015.39.5.434

Abstract

BACKGROUND
Confirmation regarding the association between impaired fasting glucose (IFG) and biomarkers in addition to metabolic components and lifestyle factors are required in the occupational filed for preventing diabetes mellitus.
METHODS
The study was performed in working men aged 30 to 60 years old, who were not taking medication for any metabolic diseases. The author measured the serum levels of high-sensitivity C-reactive protein (CRP), uric acid, and plasma fibrinogen as potential biomarkers of IFG.
RESULTS
The mean serum uric acid, log-transformed serum CRP, and plasma fibrinogen levels were higher in the subjects with IFG than in those without IFG. Multivariate analysis revealed significant associations between the presence of IFG and age, log-transformed value of serum CRP, increased waist circumference, hypertension, and hypertriglyceridemia, with odds ratios of 1.1 (95% confidence interval [CI], 1.08 to 1.1; P<0.001), 1.8 (95% CI, 1.4 to 2.3; P<0.001), 1.3 (95% CI, 1.09 to 1.7; P<0.01), 1.9 (95% CI, 1.6 to 2.3; P<0.001), and 1.3 (95% CI, 1.04 to 1.6; P<0.05), respectively, for the presence of IFG.
CONCLUSION
Serum CRP, age, and three metabolic components were associated with IFG. In contrast, there were no significant associations between IFG and lifestyle factors, serum uric acid or plasma fibrinogen.

Keyword

C-reactive protein; Fibrinogen; Impaired fasting glucose; Life style; Metabolic components

MeSH Terms

Biomarkers*
C-Reactive Protein
Diabetes Mellitus
Fasting*
Fibrinogen
Glucose*
Humans
Hypertension
Hypertriglyceridemia
Life Style*
Male*
Metabolic Diseases
Multivariate Analysis
Odds Ratio
Plasma
Uric Acid
Waist Circumference
C-Reactive Protein
Fibrinogen
Glucose
Uric Acid

Reference

1. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012; 59:635–643.

2. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J. 2010; 74:213–220.

3. Emerging Risk Factors Collaboration. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010; 375:132–140.

4. Fibrinogen Studies Collaboration. Kaptoge S, White IR, Thompson SG, Wood AM, Lewington S, Lowe GD, Danesh J. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol. 2007; 166:867–879.

5. Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study. Eur J Epidemiol. 2013; 28:541–550.

6. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, Zhang C. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013; 8:e56864.

7. Yamada T, Fukatsu M, Suzuki S, Wada T, Joh T. Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health check-ups. Diabetes Metab. 2011; 37:252–258.

8. Kawada T, Otsuka T, Inagaki H, Wakayama Y, Katsumata M. Biological markers, lifestyles and metabolic syndrome in workers. Diabetes Metab Syndr. 2015; 9:71–73.

9. Nakanishi N, Nishina K, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers. Diabetes Res Clin Pract. 2004; 63:185–194.

10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143–3421.

11. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition. Lancet. 2005; 366:1059–1062.

12. Raynaud E, Perez-Martin A, Brun J, Aissa-Benhaddad A, Fedou C, Mercier J. Relationships between fibrinogen and insulin resistance. Atherosclerosis. 2000; 150:365–370.

13. Raynaud E, Brun JF, Perez-Martin A, Orsetti A, Solere M. Negative correlation between plasma fibrinogen and insulin sensitivity measured with the minimal model technique. Clin Hemorheol Microcirc. 1998; 18:323–330.

14. Simental-Mendia LE, Lazalde B, Zambrano-Galvan G, Simental-Saucedo L, Rabago-Sanchez E, Rodriguez-Moran M, Guerrero-Romero F. Relation between C-reactive protein and impaired fasting glucose in obese subjects. Inflammation. 2012; 35:1742–1746.

15. Ye X, Franco OH, Yu Z, Li H, Hu FB, Liu H, Wang X, Tang H, Liu Y, Chen Y, Lin X. Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people. Clin Endocrinol (Oxf). 2009; 70:854–862.

16. Fagard RH, Nilsson PM. Smoking and diabetes: the double health hazard! Prim Care Diabetes. 2009; 3:205–209.

17. Kawada T. Difficulties encountered by diabetic workers in a company trying to stop smoking. J Diabetes. 2011; 3:317.

18. Kawada T. The association between physical data, mental status and blood rheology with special emphasis on smoking status, depressive state, and blood viscosity. Circ J. 2011; 75:1282.